0001382963-16-000247.txt : 20161020 0001382963-16-000247.hdr.sgml : 20161020 20161020172105 ACCESSION NUMBER: 0001382963-16-000247 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161020 DATE AS OF CHANGE: 20161020 EFFECTIVENESS DATE: 20161020 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trethera Corp CENTRAL INDEX KEY: 0001639837 IRS NUMBER: 462817645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-257926 FILM NUMBER: 161944923 BUSINESS ADDRESS: STREET 1: 3201 WILSHIRE BLVD. STREET 2: SUITE 102 CITY: SANTA MONICA STATE: CA ZIP: 90403 BUSINESS PHONE: 310-997-2788 MAIL ADDRESS: STREET 1: 3201 WILSHIRE BLVD. STREET 2: SUITE 102 CITY: SANTA MONICA STATE: CA ZIP: 90403 FORMER COMPANY: FORMER CONFORMED NAME: Triangle Therapeutics Inc. DATE OF NAME CHANGE: 20150416 D/A 1 primary_doc.xml X0707 D/A LIVE 0001639837 Trethera Corp 3201 WILSHIRE BLVD. SUITE 102 SANTA MONICA CA CALIFORNIA 90403 310-997-2788 DELAWARE Triangle Therapeutics Inc. Corporation true 2015 Johannes Czernin 3201 Wilshire Blvd. Suite 102 Santa Monica CA CALIFORNIA 90403 Director Johanna Holldack 3201 Wilshire Blvd. Suite 102 Santa Monica CA CALIFORNIA 90403 Executive Officer Director Carl W. McKinzie 10900 Wilshire Blvd. Suite 850 Los Angeles CA CALIFORNIA 90024 Executive Officer Director Lynne Rollins 3201 Wilshire Blvd. Suite 102 Santa Monica CA CALIFORNIA 90403 Executive Officer Nathan Mata 3201 Wilshire Blvd. Suite 102 Santa Monica CA CALIFORNIA 90403 Executive Officer Jean B. deKernion 3201 Wilshire Blvd. Suite 102 Santa Monica CA CALIFORNIA 90403 Director Caius Radu 3201 Wilshire Blvd. Suite 102 Santa Monica CA CALIFORNIA 90403 Director Louis L. Gonda 9350 Wilshire Blvd. Beverly Hills CA CALIFORNIA 90212 Director Biotechnology Decline to Disclose 06b true 0001382963-16-000150 2016-02-10 false true true true false 0 20000000 10049743 9950257 This amount includes preferred stock, common stock, warrants and common stock issuable upon conversion of preferred stock/exercise of warrants. false 43 0 0 0 false Trethera Corp /s/ Johanna Holldack, M.D. Johanna Holldack, M.D. President and CEO 2016-10-20